The weight loss medications that we prescribe as a part of our weight loss program in Austin, Texas, whether they are GLP-1 medications or non- GLP-1 medications, help people lose weight through different mechanisms, making them suitable for various needs and health profiles
2024 Meta-Analysis Indicates That GLP-1RAs Reduce Adverse CV Events A 2024 Meta-analysis of 13 multiple cardiovascular outcome trials has documented that GLP1-RA therapy significantly reduces the risk of major adverse cardiovascular events (MACEs), all-cause mortality, CV mortality, stroke, risk for coronary revascularization, and composite adverse kidney outcomes in both sexes, regardless of a patient's history of cardiovascular disease, BMI or eGFR (Rivera et al, 2024)
Frequently Asked Questions What should reconstituted GHK-Cu look like
As Jean-Marc says, when the nervous system is calmer, the bodys metabolic signals including GLP-1 work far more effectively. For more visit HOOKE.LONDON, ARTAH.CO & KIM-PEARSON.COM
Studies showed a remarkable effect on people with obesity: The SELECT Trial found that MACE (major adverse CVD event) risk was reduced by 20% in adults with obesity without T2D in the group taking semaglutide
Dis Markers 2007